![]() |
市場調查報告書
商品編碼
1567798
到 2030 年北美醫用超音波流量計市場預測 - 區域分析 - 按實施類型、技術、應用和最終用戶North America Medical Ultrasound Flow Meter Market Forecast to 2030 - Regional Analysis - by Implementation Type, Technology, Application, and End User |
2022年北美醫用超音波流量計市值為7,440萬美元,預計到2030年將達到1.5277億美元;預計2022年至2030年複合年成長率為9.4%。
心血管和呼吸系統疾病數量的增加推動了北美醫療超音波流量市場
全球每年有數百萬人因心血管疾病 (CVD) 死亡。根據2022年心臟病和中風統計更新說明書《全球疾病負擔》,2020年全球有1.191億患者因CVD死亡。 68.2分別為 100 萬。根據美國國家慢性病預防和健康促進中心心臟病和中風預防部門的數據,2022 年,美國約有 697,000 人患有心臟病。年,美國(佔總人口的45.1%)可能會受到某種形式的心血管疾病的影響。 ) 手術。
慢性阻塞性肺病(COPD)會阻礙肺部氣流,進而導致呼吸衰竭。它是危及生命的疾病之一,導致全世界數百萬人死亡。據世界衛生組織(WHO)稱,2022年,慢性阻塞性肺病是第三大死因。根據美國疾病管制與預防中心 (CDC) 的數據,2020 年,慢性阻塞性肺病 (COPD) 是美國第六大死因。因此,心血管疾病和呼吸系統疾病數量的增加促進了與超音波流量計結合的外部支援設備的越來越多的使用。例如,體外膜氧合(ECMO)是一種生命維持系統,透過醫用管道向患者體內泵送液體提供臨時解決方案,它與超音波流量計相結合,代替心臟或肺部工作,以確保準確的測量結果。
北美醫用超音波流量計市場概況
北美醫用超音波流量計市場分為美國、加拿大和墨西哥。心血管疾病和呼吸系統疾病盛行率的上升以及市場參與者不斷發展的策略發展有助於該地區的市場發展。美國擁有領先的醫用超音波流量計市場佔有率。
北美醫用超音波流量計市場收入及 2030 年預測(百萬美元)
北美醫用超音波流量計市場細分
北美醫用超音波流量計市場按實施、技術、應用、最終用戶和國家/地區進行分類。
依實施情況,北美醫用超音波流量計市場分為外夾式、內聯式等。 2022 年,外夾式細分市場佔據最大的市場佔有率。
從技術面來看,北美醫用超音波流量計市場分為多普勒流量計、時差流量計和混合流量計。 2022 年,多普勒細分市場佔據最大的市場佔有率。
依應用分類,北美醫用超音波流量計市場分為心肺機、體外膜氧合、灌注、器官運輸系統等。 2022 年,其他細分市場佔據最大市場佔有率。
依最終用戶分類,北美醫用超音波流量計市場分為醫院和診所、門診手術中心、研究實驗室等。 2022 年,醫院和診所細分市場佔據最大市場佔有率。
依國家/地區分類,北美醫用超音波流量計市場分為美國、加拿大和墨西哥。 2022年,美國主導北美醫用超音波流量計市場佔有率。
Arjo AB、PSG Dover、Moor Instruments Ltd、Transonic Systems Inc、Compumedics Ltd、Cook Medical Holdings LLC、GF Health Products Inc、Sonotec GmbH、StrainMeasurement Devices Inc、Siemens AG、Perimed AB 和 Sensirion Holding AG 是一些領先的公司公司在北美醫療超音波流量計市場運作。
The North America medical ultrasound flow meter market was valued at US$ 74.40 million in 2022 and is projected to reach US$ 152.77 million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030.
Rising Number of Cardiovascular and Respiratory Diseases Fuels North America Medical Ultrasound Flow Market
Millions of deaths are recorded due to cardiovascular diseases (CVDs) annually across the world. According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, 119.1 million patients succumbed to death globally due to CVD in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people were reported to have had heart disease in the US in 2022. According to the American Heart Association, over 130 million people in the US (45.1% of the total population) are likely to be affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, about 400,000 coronary artery bypass grafting (CABG) surgeries were performed in 2022.
Chronic obstructive pulmonary disease (COPD) obstructs the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to the World Health Organization (WHO), COPD was the third leading cause of death in 2022. In 2020, about 90% of COPD deaths occurred in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Thus, the increasing number of CVDs and respiratory diseases has promoted the growing use of external support devices incorporated with ultrasound flow meters. For instance, extracorporeal membrane oxygenation (ECMO)-a life support system that provides a temporary solution for pumping fluids in the patient's body through medical tubing-is incorporated with ultrasound flow meters to work in place of heart or lungs in order to ensure the accurate flow of oxygenated blood during surgical procedures.
North America Medical Ultrasound Flow Meter Market Overview
The North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The rising prevalence of cardiovascular diseases and respiratory diseases and growing strategic developments by market players contribute to the market development in the region. The US holds the leading medical ultrasound flow meter market share.
North America Medical Ultrasound Flow Meter Market Revenue and Forecast to 2030 (US$ Million)
North America Medical Ultrasound Flow Meter Market Segmentation
The North America medical ultrasound flow meter market is categorized into implementation, technology, application, end user, and country.
Based on implementation, the North America medical ultrasound flow meter market is segmented into clamp-on, inline, and others. The clamp-on segment held the largest market share in 2022.
In terms of technology, the North America medical ultrasound flow meter market is categorized into doppler, transit-time, and hybrid. The doppler segment held the largest market share in 2022.
By application, the North America medical ultrasound flow meter market is segmented into heart and lung machines, extracorporeal membrane oxygenation, perfusion, organs transportation system, and others. The others segment held the largest market share in 2022.
By end user, the North America medical ultrasound flow meter market is bifurcated into hospitals and clinics, ambulatory surgical centers, research laboratories, and others. The hospitals and clinics segment held the largest market share in 2022.
By country, the North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The US dominated the North America medical ultrasound flow meter market share in 2022.
Arjo AB, PSG Dover, Moor Instruments Ltd, Transonic Systems Inc, Compumedics Ltd, Cook Medical Holdings LLC, GF Health Products Inc, Sonotec GmbH, Strain Measurement Devices Inc, Siemens AG, Perimed AB, and Sensirion Holding AG are some of the leading companies operating in the North America medical ultrasound flow meter market.